The type 1 insulin-like growth factor receptor pathway

MM Chitnis, JSP Yuen, AS Protheroe, M Pollak… - Clinical cancer …, 2008 - AACR
Research conducted over the past two decades has shown the importance of the type 1
insulin-like growth factor receptor (IGF1R) in tumorigenesis, metastasis, and resistance to …

The insulin-like growth factor system in cancer

SJ Weroha, P Haluska - Endocrinology and Metabolism Clinics, 2012 - endo.theclinics.com
Insulin-like growth factor (IGF) plays an important role in tissue growth and development. As
such, several studies have demonstrated the association between circulating levels of IGF-1 …

Plasma levels of insulin-like growth factor-I and lung cancer risk: a case-control analysis

H Yu, MR Spitz, J Mistry, J Gu… - Journal of the National …, 1999 - academic.oup.com
BACKGROUND: Insulin-like growth factors (IGFs), in particular IGF-I and IGF-II, strongly
stimulate the proliferation of a variety of cancer cells, including those from lung cancer. To …

Multiple signaling pathways of the insulin-like growth factor 1 receptor in protection from apoptosis

F Peruzzi, M Prisco, M Dews, P Salomoni… - … and cellular biology, 1999 - Am Soc Microbiol
The type 1 insulin-like growth factor receptor (IGF-1R), activated by its ligands, protects
several cell types from a variety of apoptotic injuries. The main signaling pathway for IGF-1R …

[HTML][HTML] IGF1R signalling and its inhibition

J Riedemann, VM Macaulay - Endocrine-related cancer, 2006 - erc.bioscientifica.com
The type 1 IGF receptor (IGF1R) is a transmembrane tyrosine kinase that is frequently
overexpressed by tumours, and mediates proliferation and apoptosis protection. IGF …

Whey protein in cancer therapy: A narrative review

FJ Teixeira, HO Santos, SL Howell… - Pharmacological research, 2019 - Elsevier
Cancer remains a public health challenge in the identification and development of ideal
pharmacological therapies and dietary strategies. The use of whey protein as a dietary …

The IGF system and breast cancer.

D Sachdev, D Yee - Endocrine-related cancer, 2001 - erc.bioscientifica.com
The IGF system components have been implicated in breast cancer progression. IGF-I and
IGF-II are mitogenic and anti-apoptotic peptides that influence the proliferation of various cell …

Rapamycin causes poorly reversible inhibition of mTOR and induces p53-independent apoptosis in human rhabdomyosarcoma cells

H Hosoi, MB Dilling, T Shikata, LN Liu, L Shu… - Cancer research, 1999 - AACR
The mammalian target of rapamycin (mTOR) has been shown to link growth factor signaling
and posttranscriptional control of translation of proteins that are frequently involved in cell …

Clinical potential of novel therapeutic targets in breast cancer: CDK4/6, Src, JAK/STAT, PARP, HDAC, and PI3K/AKT/mTOR pathways

SR Hosford, TW Miller - Pharmacogenomics and personalized …, 2014 - Taylor & Francis
Breast cancers expressing estrogen receptor α, progesterone receptor, or the human
epidermal growth factor receptor 2 (HER2) proto-oncogene account for approximately 90 …

Mechanisms implicated in the growth regulatory effects of vitamin D in breast cancer.

KW Colston - Endocrine-related cancer, 2002 - erc.bioscientifica.com
It is now well established that, in addition to its central role in the maintenance of
extracellular calcium levels and bone mineralization, 1, 25-dihydroxyvitamin D (3)(1, 25 …